nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013
|
Marotta, Phillip L. |
|
2017 |
33 |
7 |
p. 679-688 |
artikel |
2 |
Age-specific ALS incidence: a dose–response meta-analysis
|
Marin, Benoît |
|
2018 |
33 |
7 |
p. 621-634 |
artikel |
3 |
A new era for dementia epidemiology: Alzheimer’s disease, hardening of arteries, or just old age?
|
Kuller, Lewis H. |
|
2018 |
33 |
7 |
p. 613-616 |
artikel |
4 |
Broadening the scope of epidemiologic dementia research
|
Darweesh, Sirwan K. L. |
|
2018 |
33 |
7 |
p. 617-620 |
artikel |
5 |
External validation of four dementia prediction models for use in the general community-dwelling population: a comparative analysis from the Rotterdam Study
|
Licher, Silvan |
|
2018 |
33 |
7 |
p. 645-655 |
artikel |
6 |
Gestational age at birth and risk of intellectual disability without a common genetic cause
|
Heuvelman, Hein |
|
2017 |
33 |
7 |
p. 667-678 |
artikel |
7 |
How accurately is euthanasia reported on death certificates in a country with legal euthanasia: a population-based study
|
Cohen, Joachim |
|
2018 |
33 |
7 |
p. 689-693 |
artikel |
8 |
Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer’s disease
|
Ower, Alison K. |
|
2017 |
33 |
7 |
p. 657-666 |
artikel |
9 |
The importance of endpoint selection: How effective does a drug need to be for success in a clinical trial of a possible Alzheimer’s disease treatment?
|
Evans, Stephanie |
|
2018 |
33 |
7 |
p. 635-644 |
artikel |
10 |
Will biomarker-based diagnosis of Alzheimer’s disease maximize scientific progress? Evaluating proposed diagnostic criteria
|
Glymour, Medellena Maria |
|
2018 |
33 |
7 |
p. 607-612 |
artikel |